Navigation Links
Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the Development, Manufacture, and Supply of Biosuperior Monoclonal Antibodies
Date:2/21/2012

13 potentially resulting in key human pharmacokinetic data validating Xtend technology.

About Xencor, Inc.

Xencor, Inc. engineers superior biotherapeutics using its proprietary Protein Design Automation® technology platform, and is a leader in the field of antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency. The company is advancing multiple XmAb® antibody drug candidates in the clinic, including XmAb®5871 targeting CD32b and CD19 for autoimmune diseases, and an anti-CD30 candidate XmAb®2513 for the treatment of Hodgkin's lymphoma. Xencor is also advancing a portfolio of biosuperior versions of blockbuster antibody drugs engineered for superior half-life and dosing schedule. Xencor has entered into multiple partnerships with industry leaders such as Amgen, Pfizer, Centocor, MorphoSys, Boehringer Ingelheim, CSL Ltd. and Human Genome Sciences. In these partnerships Xencor is applying its suite of proprietary antibody Fc domains to improve antibody drug candidates for traits such as sustained half-life and/or potency. For more information, please visit www.xencor.com.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates in 50 countries and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed for 125 years to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

Today, Boehringer Ingelheim is one of the world's leading companies for contract development and manufacture of biopharmaceuticals. All types of services from mammalian cell line or microbial strain development to final drug production can be delivered within a one-stop-shop concept. Boehringer
'/>"/>

SOURCE Xencor, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
2. AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim
3. Boehringer Ingelheim Invests More Than $350 Million in 2011 U.S. Expansion Projects
4. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
5. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
6. Boehringer Ingelheim Broadens Its Breast Cancer Clinical Trial Program for the Investigational Compound Afatinib
7. Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
8. Boehringer Ingelheim and Ashokas Changemakers Launch "Making More Health" Competition
9. Ashoka and Boehringer Ingelheim Announce a Global Partnership for "Making More Health"
10. Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
11. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 29, 2015  Daktari Diagnostics was honored at the ... in the Service of Society Award. IEEE President and CEO, ... L. Shoop presented the award to Principal Scientist ... was held Saturday, June 20, 2015, at the historic Waldorf ... "I have spent more than 3 years ...
(Date:6/29/2015)... ZIONA, Israel , June 29, 2015 ... TASE: BVXV) today announced positive preliminary results from its ... for a universal influenza vaccine. In this trial, M-001 ... 50 to 65, followed by an administration of the ... M-001 was found to be safe and well tolerated ...
(Date:6/29/2015)... , June 29, 2015 Regeneron Pharmaceuticals, ... the Proceedings of the National Academy of ... that the Company,s proprietary VelociGene ® and ... and preclinical validation of potential candidates that could ... Middle East Respiratory Syndrome (MERS). This involved the ...
Breaking Medicine Technology:Daktari Honored with IEEE Spectrum Award 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
... MedVantx, Inc., the company that created first ever controlled access ... Inc. Magazine has rated the company as one of the ... year in a row, MedVantx has made the list.  In ... thirteenth overall. The Inc. 500/5000 list is the ...
... 2011 CORPAK MedSystems, Inc., a leading ... enteral feeding and bedside-technology markets, today announced the appointment ... officer. Mr. Blair brings 40 years ... recently as the chairman and chief executive officer of ...
Cached Medicine Technology:MedVantx Honored by Inc. 500/5000 Three Years in a Row 2CORPAK MedSystems Names Jeffrey Blair Chief Executive Officer 2CORPAK MedSystems Names Jeffrey Blair Chief Executive Officer 3
(Date:6/30/2015)... ... June 30, 2015 , ... This Fourth of July, ... Peacock Alley story including hard work, tenacity, perseverance, commitment to quality, honesty and love ... , Born of Mary Ella Gabler's simple love of quilts, Peacock Alley was fully ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Curly Hair ... 14, the largest beauty event in the US, featuring products from all over the ... Keeper™ Collection. The Collection is a line of hair styling products focused entirely on ...
(Date:6/29/2015)... ... June 30, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. ... the nation’s leading networking organization exclusively for professional women, boasting more than 700,000 ...
(Date:6/29/2015)... ... June 30, 2015 , ... ... November at one of the industry’s premier thought leadership symposiums, “Harmony 2015” hosted ... of nursing, rehabilitation managers and other management and corporate personnel representing the skilled ...
(Date:6/29/2015)... , ... June 30, 2015 , ... The United ... Rehab Team (KORT) as it becomes the Official Physical and Occupational Therapists of the ... 2015 Rolex Kentucky Three-Day Event presented by Land Rover. , “The USEF is ...
Breaking Medicine News(10 mins):Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:National Association of Professional Women Inducts Melanie Richards, DMD, of Powdersville Pediatric Dentistry, Into its VIP Woman of the Year Circle 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 3Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2
... leading e-learning provider and a division of Futuremedia ... a next,generation personalised learning environment, for Bupa, the ... place at Bupa offices in Manchester and Staines ... support and overviews,of the portal,s features to Bupa ...
... Omega-3 +Plus Snack String Cheese from Sorrento(R) joins +Plus line of ... ... April 21 As consumers continue to be,increasingly health-conscious and functional ... that provide,health benefits beyond basic nutrition to meet consumer demand. In ...
... today reported that Novartis AG announced global sales of ... ended,March 31, 2008. This represents a decrease of 40.4% ... the U.S. were $9.3 million, up 10.6% from the,prior-year ... million,down 48.5% from the prior year. The drop in ...
... to be Opened in the North West of England -, ... ORCH ), a leading worldwide provider of identity DNA testing,services, ... in the North West of England later this year following ... work was awarded to Orchid,Cellmark following the North West/South West ...
... and ... ... Inc. (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today announced that ... Dr. Weber brings a wealth of experience to this position, ...
... provider of,Business Process Outsourcing solutions for health payers, ... and URL address. The new company website,is now ... also been refreshed,with useful information to help health ... business process outsourcing services., (Logo: http://www.newscom.com/cgi-bin/prnh/20050113/SFTH042LOGO ...
Cached Medicine News:Health News:Futuremedia Learning Launches Next Generation Learning Portal for Bupa 2Health News:Sorrento(R) Cheese Launches First Omega-3 Cheese on the Market 2Health News:Sorrento(R) Cheese Launches First Omega-3 Cheese on the Market 3Health News:QLT announces first quarter 2008 Visudyne(R) sales 2Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 2Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 3Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 4Health News:Bioniche Appoints U.S. President of Food Safety 2Health News:Bioniche Appoints U.S. President of Food Safety 3Health News:Bioniche Appoints U.S. President of Food Safety 4Health News:Adaptis Launches New Website and URL Address 2